- Report
- November 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 175 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2024
- 104 Pages
China
From €1718EUR$1,800USD£1,439GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- August 2024
- 204 Pages
China
From €3818EUR$4,000USD£3,199GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
The Antipyretic market is a subset of the Cough and Cold Drugs market, which includes medications used to treat symptoms of the common cold, such as fever, sore throat, and congestion. Antipyretics are drugs that reduce fever, and are often used in combination with other medications to treat colds. Common antipyretics include ibuprofen, acetaminophen, and aspirin. These drugs are available in both over-the-counter and prescription forms.
Antipyretics are widely used to treat colds, and are often recommended by doctors as part of a comprehensive treatment plan. They are generally safe and effective, and can be used to reduce fever and other symptoms associated with colds.
Some companies in the Antipyretic market include Pfizer, GlaxoSmithKline, Merck, Johnson & Johnson, and Novartis. Show Less Read more